QUOTIENT LIMITED CHANGE OF CONTROL AGREEMENTChange of Control Agreement • December 13th, 2019 • Quotient LTD • In vitro & in vivo diagnostic substances • Delaware
THIS CHANGE OF CONTROL AGREEMENT (this “Agreement”), is made on this 8th day of November, 2019, by and between QUOTIENT LIMITED, a public no par value limited liability company incorporated in Jersey, Channel Islands, with registered number 109886 (the “Company”) and Ernest Larnach (the “Employee”).
Franz WaltTransition Agreement • December 13th, 2019 • Quotient LTD • In vitro & in vivo diagnostic substances
We would like to thank you for your service to Quotient Limited (the “Company”) since joining. This letter, when fully executed, will constitute the Transition Agreement (“Agreement”) between you and the Company concerning the terms of your upcoming retirement from employment with the Company.
Dated as of December 13, 2019 QUOTIENT LIMITED and THE HOLDERS OF ORDINARY SHARES THAT ARE PARTY TO THIS AGREEMENT REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 13th, 2019 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
REGISTRATION RIGHTS AGREEMENT, dated as of December 13, 2019 (this “Agreement”), among QUOTIENT LIMITED, a limited liability no par value company incorporated under the laws of Jersey, Channel Islands (the “Company”), CHRISTOPHER J. LINDOP (“Mr. Lindop”), HEINO VON PRONDZYNSKI (“Mr. von Prondzynski”) and FRANZ WALT (“Mr. Walt”).
SENIOR MANAGEMENT SERVICE AGREEMENT Between ALBA BIOSCIENCE LIMITED (Trading as Quotient) COMPANY NUMBER: SC310584 And ERNEST LARNACHService Agreement • December 13th, 2019 • Quotient LTD • In vitro & in vivo diagnostic substances
